Covered recipient · General Payments record
LYNN SMITH
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Adult Health
General Payments · PY2021–2024
$3,010.56
- Reported across 138 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $713.91 | 32 |
| Education | $153.34 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $222.73 | 14 |
| UCB, Inc. | $147.43 | 3 |
| Janssen Biotech, Inc. | $141.36 | 8 |
| Regeneron Healthcare Solutions, Inc. | $98.35 | 1 |
| E.R. Squibb & Sons, L.L.C. | $92.17 | 1 |
| PFIZER INC. | $49.00 | 2 |
| Janssen Scientific Affairs, LLC | $32.38 | 1 |
| Lilly USA, LLC | $29.05 | 1 |
| REVANCE THERAPEUTICS, INC. | $21.59 | 1 |
| Arcutis Biotherapeutics, Inc. | $18.62 | 1 |
| Galderma Laboratories, L.P. | $14.57 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (34)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $28.12 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106125220 | CMS |
| ABBVIE INC. | $5.76 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106125222 | CMS |
| ABBVIE INC. | $26.21 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106125224 | CMS |
| ABBVIE INC. | $17.48 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106125226 | CMS |
| ABBVIE INC. | $16.06 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106125228 | CMS |
| ABBVIE INC. | $4.56 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106125230 | CMS |
| ABBVIE INC. | $23.51 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106125232 | CMS |
| ABBVIE INC. | $3.29 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106125234 | CMS |
| ABBVIE INC. | $4.31 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106125236 | CMS |
| ABBVIE INC. | $34.22 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106125238 | CMS |
| ABBVIE INC. | $26.13 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106125240 | CMS |
| ABBVIE INC. | $4.99 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106125242 | CMS |
| ABBVIE INC. | $24.40 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106125244 | CMS |
| ABBVIE INC. | $3.69 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106125246 | CMS |
| Arcutis Biotherapeutics, Inc. | $18.62 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1121109971 | CMS |
| E.R. Squibb & Sons, L.L.C. | $92.17 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101581427 | CMS |
| Galderma Laboratories, L.P. | $14.57 | 04/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145393154 | CMS |
| Janssen Biotech, Inc. | $6.49 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078373930 | CMS |
| Janssen Biotech, Inc. | $8.90 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078373978 | CMS |
| Janssen Biotech, Inc. | $7.79 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078374002 | CMS |
| Janssen Biotech, Inc. | $11.39 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078373967 | CMS |
| Janssen Biotech, Inc. | $8.32 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078373975 | CMS |
| Janssen Biotech, Inc. | $17.16 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078374026 | CMS |
| Janssen Biotech, Inc. | $54.99 | 09/24/2024 | Education | Undisputed | 01/23/2026 | 1078373959 | CMS |
| Janssen Biotech, Inc. | $26.32 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078374005 | CMS |
| Janssen Scientific Affairs, LLC | $32.38 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078846461 | CMS |
| Lilly USA, LLC | $29.05 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135828833 | CMS |
| PFIZER INC. | $24.96 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131144321 | CMS |
| PFIZER INC. | $24.04 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131965085 | CMS |
| Regeneron Healthcare Solutions, Inc. | $98.35 | 11/06/2024 | Education | Undisputed | 01/23/2026 | 1114374714 | CMS |
| REVANCE THERAPEUTICS, INC. | $21.59 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147951334 | CMS |
| UCB, Inc. | $3.66 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143328571 | CMS |
| UCB, Inc. | $25.33 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143328575 | CMS |
| UCB, Inc. | $118.44 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143353303 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.